Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...

Higher glycemia was associated with worse cognitive score outcomes among patients with short-duration type 2 diabetes at 4-year follow-up.

Novo Nordisk NVO shares have plunged 19.9% year to date, following a string of unfavorable outcomes, both pipeline and ...

Product has patent protection through 2044 - DEER PARK, Ill., July 08, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc ("Eton" or the "Company") ...

The International Diabetes Federation confirms type 5 diabetes caused by malnutrition, affecting millions of young people living in poverty.

Oral antidiabetic drugs were associated with significantly lower fracture risks than insulin among patients with type 2 diabetes.

Research shows diabetes medications may cut Alzheimer's risk by up to 43% in patients with type 2 diabetes, offering potential good news for dementia prevention ...

💊 A new international clinical trial found that oral semaglutide reduces the risk of major cardiovascular events by 14% in people with type 2 diabetes and heart or kidney disease. ️ The once ...

The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the ca ...

The evidence is clear—Type 2 diabetes does not have to be a life sentence of escalating medication use.

There are several types of diabetes medications that can promote weight loss, or that have weight loss as a side effect. These diabetes drugs for weight loss include: GLP-1 receptor Agonists .

Can certain drugs cause a person's blood sugar levels to drop too low? Read on to learn more about drug-induced hypoglycemia, including which drugs can cause low blood sugar.